These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19092418)

  • 1. Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium.
    Wu PC; Kuo HK; Tai MH; Shin SJ
    Cornea; 2009 Jan; 28(1):103-4. PubMed ID: 19092418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium.
    Fallah MR; Khosravi K; Hashemian MN; Beheshtnezhad AH; Rajabi MT; Gohari M
    Curr Eye Res; 2010 Jan; 35(1):17-22. PubMed ID: 20021250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study.
    Lekhanont K; Patarakittam T; Thongphiew P; Suwan-apichon O; Hanutsaha P
    Cornea; 2012 Feb; 31(2):155-61. PubMed ID: 22081150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical application of bevacizumab as an adjunct to recurrent pterygium surgery.
    Ozgurhan EB; Agca A; Kara N; Yuksel K; Demircan A; Demirok A
    Cornea; 2013 Jun; 32(6):835-8. PubMed ID: 23187164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium.
    Bahar I; Kaiserman I; McAllum P; Rootman D; Slomovic A
    Curr Eye Res; 2008 Jan; 33(1):23-8. PubMed ID: 18214740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of pterygium surgery with mitomycin C application using conjunctival autograft versus conjunctival-limbal autograft.
    Kheirkhah A; Hashemi H; Adelpour M; Nikdel M; Rajabi MB; Behrouz MJ
    Ophthalmology; 2012 Feb; 119(2):227-32. PubMed ID: 22153864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of recurrent pterygium with topical bevacizumab 0.05% eye drops: a randomized controlled trial.
    Kasetsuwan N; Reinprayoon U; Satitpitakul V
    Clin Ther; 2015 Oct; 37(10):2347-51. PubMed ID: 26409291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of recurrent pterygium surgery: limbal conjunctival autograft transplantation versus mitomycin C with conjunctival flap.
    Mutlu FM; Sobaci G; Tatar T; Yildirim E
    Ophthalmology; 1999 Apr; 106(4):817-21. PubMed ID: 10201608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment.
    Mauro J; Foster CS
    Semin Ophthalmol; 2009; 24(3):130-4. PubMed ID: 19437347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of subconjunctival bevacizumab on primary pterygium.
    Teng CC; Patel NN; Jacobson L
    Cornea; 2009 May; 28(4):468-70. PubMed ID: 19411971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial.
    Shenasi A; Mousavi F; Shoa-Ahari S; Rahimi-Ardabili B; Fouladi RF
    Cornea; 2011 Nov; 30(11):1219-22. PubMed ID: 21955635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferior limbal-conjunctival autograft transplantation for recurrent pterygium.
    Wong AK; Rao SK; Leung AT; Poon AS; Lam DS
    Indian J Ophthalmol; 2000 Mar; 48(1):21-4. PubMed ID: 11271929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of bare sclera, limbal-conjunctival autograft and amniotic membrane graft techniques in primary pterygium excisions.
    Ozer A; Yildirim N; Erol N; Yurdakul S
    Ophthalmologica; 2009; 223(4):269-73. PubMed ID: 19339811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subconjunctival bevacizumab injection in treatment of pterygium.
    Besharati MR; Manaviat MR; Souzani A
    Acta Med Iran; 2011; 49(3):179-83. PubMed ID: 21681707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab and ocular wound healing after primary pterygium excision.
    Banifatemi M; Razeghinejad MR; Hosseini H; Gholampour A
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):17-21. PubMed ID: 20977367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery.
    Hwang S; Choi S
    Korean J Ophthalmol; 2015 Dec; 29(6):375-81. PubMed ID: 26635453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose intraoperative mitomycin-C versus conjunctival autograft in primary pterygium surgery: long term follow-up.
    Sharma A; Gupta A; Ram J; Gupta A
    Ophthalmic Surg Lasers; 2000; 31(4):301-7. PubMed ID: 10928667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of ocular benign lymphoid hyperplasia treated with bevacizumab injection.
    Oh DH; Chun YS; Kim JC
    Korean J Ophthalmol; 2011 Feb; 25(1):57-9. PubMed ID: 21350697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results.
    Enkvetchakul O; Thanathanee O; Rangsin R; Lekhanont K; Suwan-Apichon O
    Cornea; 2011 Nov; 30(11):1213-8. PubMed ID: 21915047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of different concentrations of topical bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study.
    Motarjemizadeh Q; Aidenloo NS; Sepehri S
    Int Ophthalmol; 2016 Feb; 36(1):63-71. PubMed ID: 25943172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.